Financial Year End | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 |
---|---|---|---|---|---|---|---|---|
Revenue | 209.92M | 242.06M | 270.15M | 222.79M | 176.62M | 191.36M | 138.58M | 101.33M |
Cost of Revenue | 163.81M | 191.24M | 192.84M | 163.43M | 124.28M | 124.40M | 94.31M | 78.16M |
Gross Profit | 46.11M | 50.82M | 77.31M | 59.36M | 52.34M | 66.96M | 44.27M | 23.17M |
Operating Expenses | 92.06M | 102.03M | 107.52M | 80.41M | 62.25M | 49.90M | 34.48M | 32.50M |
Selling, General & Admin | 45.90M | 48.26M | 52.71M | 39.25M | 34.11M | 28.84M | N/A | N/A |
Research & Development | 46.16M | 53.77M | 54.81M | 41.16M | 28.14M | 21.05M | 15.12M | 15.24M |
Other Operating Expenses | 2.78M | 338.00K | 336.00K | 378.00K | 535.00K | -253.00K | 19.35M | 17.27M |
Operating Income | -45.95M | -51.21M | -30.22M | -21.05M | -9.91M | 17.06M | 9.80M | -9.34M |
Other Expenses / Income | 3.30M | -3.02M | 173.00K | 456.00K | 3.14M | -253.00K | -3.10M | -2.98M |
Before Tax Income | -42.65M | -54.23M | -30.04M | -20.59M | -6.76M | 17.54M | 6.70M | -12.32M |
Income Tax Expenses | -978.00K | 344.00K | -375.00K | 340.00K | 6.12M | 3.60M | 4.86M | 1.88M |
Net Income | -41.67M | -54.58M | -29.67M | -20.93M | -12.88M | 13.94M | 1.84M | -14.20M |
Interest Expenses | 1.34M | 529.00K | 163.00K | N/A | 2.61M | 728.00K | N/A | N/A |
Basic Shares Outstanding | 46.08M | 44.44M | 42.14M | 38.37M | 37.12M | 24.86M | 25.83M | 25.83M |
Diluted Shares Outstanding | 46.08M | 44.44M | 42.14M | 38.37M | 37.12M | 29.96M | 29.12M | 29.12M |
EBITDA | -29.92M | -31.62M | -15.16M | -7.36M | -345.00K | 25.35M | 14.62M | -4.22M |
EBITDA Margin | -14.25% | -13.06% | -5.61% | -3.30% | -0.20% | 13.25% | 10.55% | -4.17% |
EBIT | -41.31M | -53.71M | -29.88M | -20.59M | -4.16M | 18.27M | 6.70M | -12.32M |
EBIT Margin | -19.68% | -22.19% | -11.06% | -9.24% | -2.35% | 9.55% | 4.83% | -12.16% |
Financial Year End | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 |